Recurrent Respiratory Papillomatosis Clinical Trial
Official title:
Investigator Initiated Study of Effects of Progression of Recurrent Respiratory Papillomatosis in Patients After They Are Given Human Papillomavirus Quadrivalent Vaccine
The purpose of this study is to determine if administration of the HPV quadrivalent vaccine in patients diagnosed with RRP has a therapeutic effect on their clinical course. More specifically, does administration of the vaccine decrease the size and number of papillomas, severity of disease (i.e. hoarseness, inspiratory vs. biphasic stridor, airway obstruction) using the LCAS and time interval between required surgical debulking will be analyzed.
Patients who carry the diagnosis of Recurrent Respiratory Papillomatosis (RRP) will be asked to participate in the study. These patients have been followed by the faculty investigator for several years. Their disease state requires frequent interventions aimed at decreasing the severity and symptomatology of their vocal fold papillomas. Patients will be given the human papillomavirus quadrivalent vaccine and their clinical course will be followed over the next 6 months. Patients will have a laryngoscopic examination prior to treatment to establish their baseline disease state. They will have repeat laryngoscopic examinations at the time of the first, second and third vaccine injections, which will be given 1 month intervals for a total of 3 doses. They will have physical exam and laryngoscopic examinations at 1 month intervals for the first 6 months after administration of the vaccine. The severity of their clinical disease will be objectively measured using a validated scale for RRP assessment, the Laryngoscopic and Clinical Assessment Scale (LCAS). ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02854761 -
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
|
Phase 1 | |
Terminated |
NCT00747461 -
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
|
Phase 4 | |
Completed |
NCT01020747 -
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
|
Phase 1 | |
Completed |
NCT00038714 -
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Completed |
NCT00205374 -
Use of Cidofovir for Recurrent Respiratory Papillomatosis
|
Phase 4 | |
Active, not recruiting |
NCT04724980 -
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04645602 -
Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement
|
Phase 2 | |
Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
Withdrawn |
NCT01058317 -
Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
|
Phase 2/Phase 3 | |
Completed |
NCT00550914 -
Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP
|
N/A | |
Not yet recruiting |
NCT01995721 -
4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
|
Phase 3 | |
Completed |
NCT02217358 -
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
|
N/A | |
Completed |
NCT00571701 -
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Recruiting |
NCT02555800 -
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Completed |
NCT03707587 -
M7824 in People With Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Completed |
NCT02859454 -
Avelumab for People With Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Active, not recruiting |
NCT02632344 -
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
|
Phase 2 | |
Completed |
NCT02592902 -
Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
|
N/A | |
Recruiting |
NCT06412172 -
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
|
||
Recruiting |
NCT03465280 -
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
|